Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:Advance care planning in patients with advanced cancer : a 6-country, cluster-randomised clinical trial
Avtorji:ID Korfage, Ida Joanna (Avtor)
ID Carreras, Giulia (Avtor)
ID Arnfeldt Christiansen, Caroline M. (Avtor)
ID Billekens, Pascalle (Avtor)
ID Bramley, Louise (Avtor)
ID Briggs, Linda (Avtor)
ID Bulli, Francesco (Avtor)
ID Caswell, Glenys (Avtor)
ID Červ, Branka, Klinika Golnik (Avtor)
ID Delden, Johannes JM van (Avtor)
ID Kodba Čeh, Hana, Klinika Golnik (Avtor)
ID Lunder, Urška, Klinika Golnik (Avtor)
ID Mimič, Alenka, Klinika Golnik (Avtor)
ID Ozbič, Polona, Klinika Golnik (Avtor)
ID Simonič, Anja, Klinika Golnik (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (986,49 KB)
MD5: 6F6F885E154016DB989E75E8907A632B
 
.zip ZIP - Priloga, prenos (109,25 KB)
MD5: ED0EAA1A09EC15B120E28CD79FA3045F
 
URL URL - Izvorni URL, za dostop obiščite https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003208
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:Background. Advance care planning (ACP) supports individuals to define, discuss, and record goals and preferences for future medical treatment and care. Despite being internationally recommended, randomised clinical trials of ACP in patients with advanced cancer are scarce. Methods and findings. To test the implementation of ACP in patients with advanced cancer, we conducted a cluster-randomised trial in 23 hospitals across Belgium, Denmark, Italy, Netherlands, Slovenia, and United Kingdom in 2015–2018. Patients with advanced lung (stage III/IV) or colorectal (stage IV) cancer, WHO performance status 0–3, and at least 3 months life expectancy were eligible. The ACTION Respecting Choices ACP intervention as offered to patients in the intervention arm included scripted ACP conversations between patients, family members, and certified facilitators; standardised leaflets; and standardised advance directives. Control patients received care as usual. Main outcome measures were quality of life (operationalised as European Organisation for Research and Treatment of Cancer [EORTC] emotional functioning) and symptoms. Secondary outcomes were coping, patient satisfaction, shared decision-making, patient involvement in decision-making, inclusion of advance directives (ADs) in hospital files, and use of hospital care. In all, 1,117 patients were included (442 intervention; 675 control), and 809 (72%) completed the 12-week questionnaire. Patients’ age ranged from 18 to 91 years, with a mean of 66; 39% were female. The mean number of ACP conversations per patient was 1.3. Fidelity was 86%. Sixteen percent of patients found ACP conversations distressing. Mean change in patients’ quality of life did not differ between intervention and control groups (T-score −1.8 versus −0.8, p = 0.59), nor did changes in symptoms, coping, patient satisfaction, and shared decision-making. Specialist palliative care (37% versus 27%, p = 0.002) and AD inclusion in hospital files (10% versus 3%, p < 0.001) were more likely in the intervention group. A key limitation of the study is that recruitment rates were lower in intervention than in control hospitals. Conclusions. Our results show that quality of life effects were not different between patients who had ACP conversations and those who received usual care. The increased use of specialist palliative care and AD inclusion in hospital files of intervention patients is meaningful and requires further study. Our findings suggest that alternative approaches to support patient-centred end-of-life care in this population are needed.
Ključne besede:advanced care planning, medical treatment, advanced cancer, palliative care
Leto izida:2020
Status objave pri reviji:Objavljeno
Verzija članka:Založnikova različica članka
Založnik:Public Library of Science
Št. strani:str. 1-16
Številčenje:Vol. 17, no. 11
Izvor:ZDA
PID:20.500.12556/DiRROS-12898 Novo okno
UDK:616
ISSN pri članku:1549-1676
DOI:10.1371/journal.pmed.1003422 Novo okno
COBISS.SI-ID:38458371 Novo okno
Avtorske pravice:© 2020 Korfage et al.
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 20. 11. 2020; Soavtorice iz Slovenije: Branka Červ, Hana Kodba-Čeh, Urška Lunder, Alenka Mimić, Polona Ozbič, Anja Simonič;
Datum objave v DiRROS:14.12.2020
Število ogledov:949
Število prenosov:861
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:AddThis
AddThis uporablja piškotke, za katere potrebujemo vaše privoljenje.
Uredi privoljenje...

Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:PLoS medicine
Skrajšan naslov:PLoS med.
Založnik:Public Library of Science
ISSN:1549-1676
COBISS.SI-ID:2944020 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:13.11.2020

Sekundarni jezik

Jezik:Ni določen
Ključne besede:vnaprejšnje načrtovanje oskrbe, napredovali rak, paliativna nega, zdravljenje


Nazaj